title: [Therapeutic effect of Xincang Decoction on chronic airway inflammation in children with bronchial asthma in remission stage].
abstract: OBJECTIVE
  To observe the therapeutic effect of Xincang Decoction on chronic airway inflammation in children with asthma in clinical investigation.
  
  
  METHODS
  Xincang Decoction was composed of Flos Magnoliae (Xinyi) and Fructus Xanthii (Cangoerzi), the traditional Chinese herbs for expelling wind. Sixty cases of children with bronchial asthma in remission stage were randomly divided into two groups. Thirty cases in the treatment group were treated with Xincang Decoction and the others in the control group were treated with ketotifen fumarate. The therapeutic effects of the two groups were compared, and the peripheral eosinophil (EOS) count, the levels of immunoglobulin E (IgE), interleukin 4 (IL-4) and interleukin 5 (IL-5), and the pulmonary functions were observed before and three months after the treatment.
  
  
  RESULTS
  After three months treatment, the results showed that the total response rates of the treatment and the control group were 83.3% and 80.0%, respectively, without marked difference (P>0.05). The levels of EOS and IL-5 were obviously decreased after the treatment, and the levels of EOS and IL-5 of the patients in the treatment group were lower than those in the control group (P<0.05). Meanwhile the forced expiratory volume in one second (FEV(1)) was improved after the treatment, and the FEV(1) of the patients in the treatment group was higher than that of the patients in the control group (P<0.05).
  
  
  CONCLUSIONS
  Xincang Decoction can decrease the levels of EOS and IL-5 and improve the pulmonary function in treating chronic airway inflammation in children with bronchial asthma in remission stage.
authors.affiliation: Department of Pediatrics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China. since1d@yahoo.com.cn
authors.forename: Hui-Hua
authors.initials: HH
authors.lastname: Zhu
authors.forename: Yan-Ping
authors.initials: YP
authors.lastname: Chen
authors.forename: Jian-Er
authors.initials: JE
authors.lastname: Yu
authors.forename: Min
authors.initials: M
authors.lastname: Wu
authors.forename: Zhan
authors.initials: Z
authors.lastname: Li
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D004804:Eosinophils; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D015848:Interleukin-5 / Q000097:blood; D008297:Male; D008517:Phytotherapy
chemical_list: D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D004365:Drugs, Chinese Herbal; D015848:Interleukin-5; D007073:Immunoglobulin E